期刊文献+

刺激响应型脂质体在靶向药物递送系统中应用 被引量:5

Research Advances on Stimuli-responsive Liposomes in the Targeted Drug Delivery System
下载PDF
导出
摘要 脂质体作为一种纳米载体,因低毒性、良好的生物相容性和生物降解性等优势已广泛应用于药物递送系统,但目前脂质体药物仍存在药物释放缓慢、靶向性低、生物利用度不足等问题。因此,引入刺激响应型脂质体这类新型药物递送系统尤为关键,以期有效提高药物靶向性、摄取率和生物利用度,并减少药物毒副作用。刺激响应型脂质体可在循环系统及正常组织或细胞内保持结构稳定,递送至目标部位后,则可在相应内外部刺激条件下被激活,释放运载物,从而对目标部位进行精准治疗。本文重点介绍pH敏感型脂质体和热敏脂质体两类刺激响应型脂质体的设计、作用原理与近期研究应用,讨论有关脂质体常见的靶向修饰方法,并对刺激响应型脂质体在药物递送领域仍面临的问题与发展前景作概括展望。 Liposome,a kind of nanoscale vesicle,is applied in the drug delivery systems(DDS)extensively because of its low toxicity,biodegradability and biocompatibility.However,defects of liposome drugs,such as low rates of drug release,insufficiency in active targeting and inefficient bioavailability still remain to be solved.Therefore,stimuli-responsive liposomes are brought to DDS to improve the efficacy of controlled drug release,assure specific release in targeted sites and alleviate side-effects as much as possible.Stimuli-responsive liposomes could maintain stability in circulation,tissues and cells under physiological conditions.Once delivered,they could be activated by relevant internal or external stimuli to release cargos accurately in target areas.This review highlights the design,functional principles and recent advances on application of pH-sensitive liposomes and thermosensitive liposomes respectively,which are two typical stimuli-responsive liposomes.Common targeting modifications of liposomes are discussed as well.We also summarize recent challenges of stimuli-responsive liposomes and their further applications.
作者 杨治中 王梓亭 魏鹏 YANG Zhi-Zhong;WANG Zi-Ting;WEI Peng(School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100029,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2020年第12期1395-1403,共9页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金项目(No.31800652)资助。
关键词 pH敏感型脂质体 热敏脂质体 刺激响应 药物递送系统 pH-sensitive liposomes(PSL) thermosensitive liposome(TSL) stimuli-responsive drug delivery system
  • 相关文献

参考文献7

二级参考文献59

  • 1张小滨,金义光,谢英,徐昆,侯新朴.RMP-7及其衍生物对脂质体跨血脑屏障作用的影响[J].药学学报,2003,38(11):867-870. 被引量:10
  • 2Sugawara S. Randomized phase n trial of uracilltegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage m non-small-cell lung cancer: NJLCG 0601[J]. Lung Cancer ,2013,81 ( I ) :91 - 96. 被引量:1
  • 3Qin Y. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery[J]. IntJ Pharmaceutics,2011,419( 1-2) :85 -95. 被引量:1
  • 4LuoJQ. Pharmacokinetic study of ZS-1 , a targeted peptide to NCI-H1299 ,in rats following intravenous administration[J] . Chromatographia , 20 11 ,73 (1-2): 177 - 181. 被引量:1
  • 5Maeda N. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome[J] .JCR,2004,l00(3) :41 -52. 被引量:1
  • 6Chertok B. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking[J]. Biomaterials ,2009,30 (35) :6780 - 6787. 被引量:1
  • 7LiJ. Targeting the brain with PEGPLGA nanoparticles modified with phage-displayed peptides[J] . Biomaterials , 2011,32(21) :4943 -4950. 被引量:1
  • 8Zhan C. Cyclic RGD conjugated poly ( ethyleneglycol) -co?poly (lactic acid) micelle enhances paclitaxel anti?glioblas-toma effect[J].J Control Release, 2010, 143 (1) : 136 - 142. 被引量:1
  • 9Shah N. Paclitaxel-loaded PLGA nanparticles surface modified with transferrin and Pluronic _ P85, an in vitro cell line and in vivo biodistribution studies on rat model[J].J Drug Target ,2009 ,17 (7) :533 - 542. 被引量:1
  • 10Gao HL. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein[J] . Biomaterials , 2011 , 32( 33) :8669 - 8675. 被引量:1

共引文献33

同被引文献48

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部